Sunhawk Vision Biotech, Inc. (TPEX:7759)

Sunhawk Vision Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	May 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Market Capitalization	2,340	4,414	-	-
Enterprise Value	1,945	3,967	-	-
Last Close Price	33.40	63.00	-	-
PB Ratio	4.96	9.36	-	-
P/TBV Ratio	5.83	10.99	-	-
Debt / Equity Ratio	0.01	0.01	0.03	0.01
Net Debt / Equity Ratio	-0.84	-0.84	-0.65	-0.73
Net Debt / EBITDA Ratio	2.27	2.27	1.94	2.00
Net Debt / FCF Ratio	2.72	2.72	2.01	2.88
Quick Ratio	16.15	16.15	30.28	27.44
Current Ratio	16.48	16.48	32.62	28.68
Return on Equity (ROE)	-44.89%	-44.89%	-28.80%	-
Return on Assets (ROA)	-27.14%	-27.14%	-20.08%	-
Return on Capital Employed (ROCE)	-37.00%	-37.00%	-33.50%	-36.20%
Earnings Yield	-7.37%	-3.91%	-	-
FCF Yield	-6.21%	-3.29%	-	-
Buyback Yield / Dilution	-12.09%	-12.09%	-0.92%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 30, 2026

Data Sources Report a data error